Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jiajia Mai"'
Autor:
Haiyan Jia, Jiajia Mai, Min Wu, Hong Chen, Xiaojiao Li, Cuiyun Li, Jingrui Liu, Chengjiao Liu, Yue Hu, Xiaoxue Zhu, Xiuhong Jiang, Bo Hua, Tian Xia, Gang Liu, Aiyun Deng, Bo Liang, Ruoling Guo, Hui Lu, Zhe Wang, Huanming Chen, Zhijun Zhang, Hong Zhang, Junqi Niu, Yanhua Ding
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Hepatitis B virus (HBV) core protein-targeting antivirals (CpTAs) are promising therapeutic agents for treating chronic hepatitis B (CHB). In this study, the antiviral activity, pharmacokinetics (PK), and tolerability of ZM-H1505R
Externí odkaz:
https://doaj.org/article/02bce6f28a1643cd90afd9d651ebfed5
Autor:
Jie Yan, Ying Li, Shiying He, Jiajia Mai, Hong Zhang, Xiaojiao Li, Yue Hu, Lizhi Yang, Min Wu, Jingchao Sun, Jinfeng Li, Wenjie Xu
Publikováno v:
Expert opinion on investigational drugs. 31(9)
Background This study evaluated the safety, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of single ascending doses (SAD) and multiple ascending doses (MAD) of S086 in healthy Chinese volunteers. Research design and methods This randomized,
Autor:
Lizhi Yang, Wenhao Yan, Jiajia Mai, Wenqiang Wu, Min Wu, Junqi Niu, Dong Zhang, Hong Zhang, Yanan Tang, John Mao, Cuiyun Li, Yanhua Ding
Publikováno v:
Antimicrob Agents Chemother
Hepatitis B virus capsid assembly modulators (HBV CAMs) are promising, clinically validated therapeutic agents for the treatment of chronic hepatitis B (CHB). The safety, tolerability, and pharmacokinetic (PK) profiles of GST-HG141, a novel HBV CAM,
Autor:
Jiajia Mai, Hong Zhang, Min Wu, Hong Chen, Yue Hu, Xiaoxue Zhu, Xiuhong Jiang, Bo Hua, Tian Xia, Gang Liu, Aiyun Deng, Bo Liang, Ruoling Guo, Hui Lu, Zhe Wang, Ming Ren, Huanming Chen, Zhijun Zhang, Junqi Niu, Yanhua Ding
Publikováno v:
Journal of Hepatology. 77:S837
Autor:
Jiajia Mai, Hong Zhang, Min Wu, Yanhua Ding, Junqi Niu, Vadim Bichko, Yanan Tang, Wenhao Yan, John Mao, Dong Zhang, Wenqiang Wu, Hong Ren, George Zhang, Hongming Li, Shikui Chen, Yanhua Zhang, Jiang Zhigan, Haiying He, Shuhui Chen
Publikováno v:
Journal of Hepatology. 77:S865
Autor:
Jiajia Mai, Tao Yang, Yanhua Ding, Jianqiu Cheng, Hong Zhang, Min Wu, Cuiyun Li, Xiumei Chi, Junqi Niu, Wei Xiang, Xiuzhu Gao
Publikováno v:
European Journal of Pharmaceutical Sciences. 165:105923
Objective Recombinant human albumin (rHA) is an alternative to human serum albumin (HSA) for treating ascites in cirrhosis patients. This study was to evaluate the safety, tolerability, immunogenicity, and pharmacokinetics/pharmacodynamics (PK/PD) of